Help Sophia Glenn Fight The Cancer - Raising funds for unfunded medication, $12,000 - $15,000 per month.

We have changed from Encorafenib, Binimetinib and Cetuximab to Dabrafenib and the Cetuximab. Specialists advised that Dabrafenib is very similar to Encorafenib except it is cheaper and has more side effects. If we had of gone with Encorafenib the cost would been 1.5-2x more than the initial $80,000.

Binimetinib also costs and was an option for Sophia however some trials that tested its efficacy found there was only a very small, statistically insignificant improvement by using it as well.

You can read more from the link below...

https://www.rnz.co.nz/news/national/536416/kiwis-call-for-wider-access-of-newly-funded-cancer-drug?fbclid=IwY2xjawHHF7tleHRuA2FlbQIxMAABHQD4VZbgXyQInGxuXn-vbA_WO8rsTqlS7OUXl8SELfcKTqXm26av0usYfQ_aem_h9wwYZUiDGARLNdhPa0RuQ

Thank you all so much for your kind words and generosity!